ErectiStim

ErectiStim is a medical technology company focused on treating erectile dysfunction (ED) through non-invasive bioelectric signaling. A portfolio company of Leonhardt Ventures and part of the Lionheart Health ecosystem, it develops the MyoStim ED platform, which uses specific electrical frequencies to stimulate the body's natural release of regenerative proteins like VEGF, Follistatin, and SDF-1. These signals are designed to promote angiogenesis, muscle repair, and nerve regeneration in penile tissue, aiming for long-term functional recovery rather than temporary symptom relief. The company offers both clinical and home-based devices, with advanced versions incorporating biologics such as platelet-rich fibrin (PRF) and stem cells. Clinical studies have demonstrated significant improvements in erectile function, positioning the technology as a restorative alternative to traditional pharmaceuticals.